Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...

Полное описание

Библиографические подробности
Главные авторы:	Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah
Формат:	Статья
Язык:	English
Опубликовано:	MDPI AG 2020-12-01
Серии:	Vaccines
Предметы:	RNA vaccines mRNA vaccines saRNA vaccines pandemic-response vaccine production COVID-19 production process modelling
Online-ссылка:	https://www.mdpi.com/2076-393X/9/1/3

Схожие документы

A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
по: Robin John Shattock, и др.
Опубликовано: (2023-11-01)

Vaccines’ New Era-RNA Vaccine
по: Wenshuo Zhou, и др.
Опубликовано: (2023-08-01)

Advancing mRNA technologies for therapies and vaccines: An African context
по: Dylan Kairuz, и др.
Опубликовано: (2022-10-01)

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
по: Bruna Aparecida Souza Machado, и др.
Опубликовано: (2021-11-01)

Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens
по: Janne Snoeck, и др.
Опубликовано: (2023-11-01)

The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review
по: Reese Jalal Ladak, и др.
Опубликовано: (2022-05-01)

Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
по: Yalan Liu, и др.
Опубликовано: (2023-06-01)

In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
по: Alexey D. Perenkov, и др.
Опубликовано: (2023-10-01)

Editorial: RNA vaccines for prevalent and newly emerging diseases
по: César López-Camacho, и др.
Опубликовано: (2024-08-01)

Development of mRNA rabies vaccines
по: Zixin Fang, и др.
Опубликовано: (2024-12-01)

A Lipid Nanoparticle-Formulated Self-Amplifying RNA Rift Valley Fever Vaccine Induces a Robust Humoral Immune Response in Mice
по: Paul K. Kitandwe, и др.
Опубликовано: (2024-09-01)

Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines
по: Dylan Kairuz, и др.
Опубликовано: (2023-04-01)

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
по: Min Tang, и др.
Опубликовано: (2023-04-01)

Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
по: Ziqi Cheng, и др.
Опубликовано: (2024-12-01)

Post-RNA (mRNA) Vaccination Myocarditis: CMR Features
по: Karuna M. Das, и др.
Опубликовано: (2022-04-01)

RNA-based vaccines – types, strategies of delivery and overview of RNA vaccines
по: Barbara Rusinowska, и др.
Опубликовано: (2022-08-01)

Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
по: Qi Ma, и др.
Опубликовано: (2025-01-01)

An mRNA vaccine against rabies provides strong and durable protection in mice
по: Miao Li, и др.
Опубликовано: (2023-10-01)

Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19
по: Shehzad M. Iqbal, и др.
Опубликовано: (2024-08-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
по: Amparo L. Figueroa, и др.
Опубликовано: (2025-12-01)

mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
по: Alireza Shariati, и др.
Опубликовано: (2024-12-01)

RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
по: Mohammad Natami, и др.
Опубликовано: (2024-03-01)

Serological findings following the second and third SARS‐CoV‐2 vaccines in lung transplant recipients
по: Enikő Bárczi, и др.
Опубликовано: (2022-08-01)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
по: Albert Liu, и др.
Опубликовано: (2022-07-01)

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
по: Girolamo Giannotta, и др.
Опубликовано: (2023-03-01)

Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines
по: Teresa Aydillo, и др.
Опубликовано: (2024-12-01)

Effectiveness of mRNA COVID-19 Vaccination on SARS-CoV-2 Infection and COVID-19 in Sicily over an Eight-Month Period
по: Emanuele Amodio, и др.
Опубликовано: (2022-03-01)

Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development
по: Emma N. Welbourne, и др.
Опубликовано: (2024-03-01)

Universal Flu mRNA Vaccine: Promises, Prospects, and Problems
по: Andrei A. Deviatkin, и др.
Опубликовано: (2022-04-01)

An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
по: Md. Motiar Rahman, и др.
Опубликовано: (2021-03-01)

Editorial: Building public confidence in innovative mRNA vaccines
по: Jia Hu, и др.
Опубликовано: (2025-01-01)

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
по: Vivek P. Chavda, и др.
Опубликовано: (2023-02-01)

Advances in nucleic acid-based cancer vaccines
по: Hung-Chun Liao, и др.
Опубликовано: (2025-01-01)

Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
по: Yu-Jing Fan, и др.
Опубликовано: (2021-09-01)

Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain
по: Zoltán Kis
Опубликовано: (2022-02-01)

A Multicenter Cohort Study on the Adverse Effects Evaluation After Messenger RNA COVID-19 Vaccination Among Pregnant Healthcare Employees in Penang General Hospitals
по: Ann Lisa Arulappen, и др.
Опубликовано: (2022-05-01)

mRNA Technology and Mucosal Immunization
по: Antonio Toniolo, и др.
Опубликовано: (2024-06-01)

Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
по: Dimitri Papukashvili, и др.
Опубликовано: (2022-10-01)

Dendrimer-Mediated Delivery of DNA and RNA Vaccines
по: Lyubov A. Kisakova, и др.
Опубликовано: (2023-03-01)

The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients
по: Nicole V. Tolan, и др.
Опубликовано: (2022-04-01)